三生制药12亿美元卖掉一款新药,创下国产药交易价新高

界面
20 May

图片来源:视觉中国界面新闻记者 |黄华界面新闻编辑 |谢欣5月20日,三生制药宣布,在研双抗PD-1/VEGF产品SSGJ-707已与辉瑞(Pfizer)达成授权合作。据公告,辉瑞将独家获得SSGJ-707在全球(不包括中国内地)的开发、生产、商业化权益;三生制药、沈阳三生将保留SSGJ-707在中国内地的相关权益。这起商业授权(BD)也凭借12.5亿美元的首付款成为了国内迄今为止首付款最高的交易...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10